Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, baricitinib, a JAK inhibitor, was found to significantly improve scalp hair regrowth in both adults and adolescents with severe alopecia areata, with many achieving nearly full regrowth by weeks 36 or 52.

This study suggests that deficiencies in certain amino acids, like taurine and tryptophan, in artificial milk formulas may contribute to skin and eye problems in Bengal tiger cubs.

This case report details a patient with alopecia areata treated with wet cupping and Ayurvedic Rasayan therapy, observing complete hair regrowth in two bald patches after a month of treatment.

This study explores how Dhatryadi rasayana, a polyherbal formulation with antioxidant properties, may help prevent and treat premature hair greying by addressing factors such as oxidative stress, nutritional deficiencies, and hormone imbalances, potentially through rasayana therapy.

This study found that while a modified BASP classification for pattern hair loss could classify previously unrecognized types, it was less accurate and harder to use than the existing BASP classification.

This study introduces a tabletop technique demonstrating that endogenous biomagnetic fields from human hair can induce red blood cells agglutination and Rouleaux formations.

This study found that blocking GABA(A) receptors in cat dorsal horn neurons increased evoked activity and background discharge, highlighting differences in inhibitory control systems compared to glycine receptors.

In this article, the author reports a case where hemiballismus was almost completely suppressed within 48 hours of starting haloperidol therapy, suggesting a therapeutic response to the drug.

PABA helps prevent gray hair and hair loss in mice.

In this case study, a 22-year-old woman with hair fall, dryness, and thinness on her scalp experienced improved blood circulation, hair growth, and shine after using Nilibhrungarajadi tailam, an Ayurvedic herbal oil, for head massage and hair care.

In two phase 3 clinical trials, this study found that adults with severe alopecia areata receiving baricitinib experienced significant hair regrowth on the scalp, eyebrows, and eyelashes over 36 weeks compared to placebo, although longer-term data are needed to fully assess benefits and risks.

In clinical trials, baricitinib showed significant hair regrowth in patients with severe alopecia areata, especially those with a SALT score of 50 or higher, according to this research. Baricitinib is noted as an alternative to corticosteroids and other JAK inhibitors.

In this clinical study, researchers found that treating hair loss with Anutaila Nasya combined with Keshamitra Yoga was more effective in alleviating symptoms of Keshpatana compared to Keshamitra Yoga alone, with a significant reduction in hair fall observed.

This study found that bimatoprost 0.03% solution may effectively reduce alopecia severity and promote cosmetically acceptable hair regrowth in some patients with scalp alopecia areata.

This single patient case report observed that Vidarikandadi Kala Basti, an Ayurvedic Panchakarma procedure, was linked to modest improvements in Vitamin B12 levels and clinical symptoms, but larger studies are needed to determine its potential role in managing Vitamin B12 deficiency.

This study found that baricitinib, taken for 24 weeks, significantly reduced alopecia severity in patients with moderate-to-severe alopecia areata, with 50% showing marked improvement and overall favorable safety and efficacy reported.

This study highlighted knuckle hyperpigmentation as an early sign of vitamin B12 deficiency, indicating a potential link to megaloblastic anemia in the vegetarian population in India.

This study examined phase 3 clinical trial data and found that baricitinib improves hair regrowth in adults with alopecia areata and significant scalp hair loss, with the response varying based on the severity of hair loss at the start of treatment.

This paper discusses the traditional use of Siddha medicines for hair growth and treating hair loss, claiming they effectively address hair fall, baldness, and dandruff without side effects, potentially due to lifestyle factors like diet and stress influencing hair health through imbalances in "pitha.

This study found that prototype right heart circulatory assist devices significantly improved hemodynamics and reduced pulmonary vascular resistances in piglet models of acute hemodynamic shock.

This study found that combining bone marrow aspirate concentrate with platelet-rich plasma significantly improved wound healing in mice compared to other treatments.

This study observed that Varnadi Kashayam, a traditional Ayurvedic decoction, demonstrated anti-inflammatory, pancreatic lipase inhibition, and anti-obesity effects in high-fat diet-induced obese rats, with research also establishing analytical specifications for its quality control and standardization.

In this report, a 58-year-old woman with ocular myasthenia gravis experienced complete resolution of symptoms and hair regrowth after six months of treatment with the JAK inhibitor baricitinib, highlighting a potential new therapeutic approach for this condition.

In this case study, a daily morning Detox Drink combined with Malasana improved bowel frequency, stool consistency, and other constipation-related symptoms in a 37-year-old woman with chronic Malabaddha.

This case report describes a child with alopecia areata and atopic dermatitis who showed significant improvement after treatment with baricitinib and corticosteroid ointment, suggesting their potential efficacy and safety.

This study mapped the curly mutation in mice to a specific region on chromosome 11, identifying it as a candidate model for studying human genetic hair disorders.

This literature review on JAK inhibitors reports that ocular side effects are rare but could be significant, with an inability to establish a causal link. Clinicians are advised to monitor such adverse events and report them to drug safety agencies.

This article discusses the role of interleukin-15 and Janus kinase inhibitors in alopecia areata based on a murine model and reports no new experimental results.

This study observed that over 60 days, Amalaki Churna, when administered to 30 patients with non-cicatricial hair fall, significantly reduced hair fall and improved hair tensile strength without adverse effects, suggesting beneficial Rasayana and Keshya properties.

Chikungunya can cause hyperpigmentation in children and should be considered in diagnosis.